UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 226

Sortiert nach

Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase

The New England journal of medicine, 2016-11, Vol.375 (18), p.1717-1725

2016

Link zum Volltext

Verfügbarkeit prüfen

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

The Lancet (British edition), 2015-09, Vol.386 (9997), p.974-981

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

JAMA neurology, 2020-09, Vol.77 (9), p.1079

2020

Link zum Volltext

Verfügbarkeit prüfen

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer

PloS one, 2016-05, Vol.11 (5), p.e0154507-e0154507

2016

Link zum Volltext

Verfügbarkeit prüfen

Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis

Intensive care medicine, 2017-06, Vol.43 (6), p.785-794

2017

Link zum Volltext

Verfügbarkeit prüfen

New‐onset atrial fibrillation incidence and associated outcomes in the medical intensive care unit

Pacing and clinical electrophysiology, 2021-08, Vol.44 (8), p.1380-1386

2021

Link zum Volltext

Verfügbarkeit prüfen

Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers

International journal of health geographics, 2017-09, Vol.16 (1), p.35-35, Article 35

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir

Drug design, development and therapy, 2016-01, Vol.10, p.2713-2722

2016

Link zum Volltext

Verfügbarkeit prüfen

Renal scintigraphy in insulin-dependent diabetes mellitus: Early glomerular and urologic dysfunction

The Journal of diabetic complications, 1990-07, Vol.4 (3), p.113-118

1990

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland

PloS one, 2018-04, Vol.13 (4), p.e0194117-e0194117

2018

Link zum Volltext

Verfügbarkeit prüfen

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response

Acta neurologica Scandinavica, 2018-11, Vol.138 (5), p.447-453

2018

Link zum Volltext

Verfügbarkeit prüfen

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study

BMC neurology, 2013-07, Vol.13 (1), p.80-80, Article 80

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-06, Vol.371 (9630), p.2085-2092

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial

Lancet neurology, 2020-12, Vol.19 (12), p.998-1009

2020

Link zum Volltext

Verfügbarkeit prüfen

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis

PloS one, 2017-01, Vol.12 (1), p.e0168834-e0168834

2017

Link zum Volltext

Verfügbarkeit prüfen

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.209-220

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis

International journal of molecular sciences, 2017-09, Vol.18 (10), p.2061

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study

Journal of neurology, neurosurgery and psychiatry, 2017-08, Vol.88 (8), p.621

2017

Link zum Volltext

Verfügbarkeit prüfen

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

Journal of neurology, neurosurgery and psychiatry, 2016-10, Vol.87 (10), p.1133-1137

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2019-05, Vol.90 (5), p.514

2019

Link zum Volltext

Verfügbarkeit prüfen

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics

PloS one, 2017-08, Vol.12 (8), p.e0182647-e0182647

2017

Link zum Volltext

Verfügbarkeit prüfen

Geographical variations in sex ratio trends over time in multiple sclerosis

PloS one, 2012-10, Vol.7 (10), p.e48078-e48078

2012

Link zum Volltext

Verfügbarkeit prüfen

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Gut, 2017-05, Vol.66 (5), p.839

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 226

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

ThemaNeurosciences

ThemaHumans

ThemaMiddle Aged

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(217)

Publikationsform

Artikel
(226)

Sprache

Englisch
(226)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Male
(218)
Female
(216)
Science & Technology
(214)
Adult
(206)
Multiple Sclerosis
(198)
Life Sciences & Biomedicine
(116)
Neurology
(98)
Multidisciplinary Sciences
(97)
Science & Technology - Other Topics
(97)
Young Adult
(81)
Medicine
(71)
Magnetic Resonance Imaging
(68)
Studies
(66)
Adolescent
(59)
Aged
(58)
Clinical Neurology
(48)
Neurosciences & Neurology
(48)

12 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(100)
Bmc Neurology
(13)
Clinical Neurology And Neurosurgery
(8)
Lancet Neurology
(8)
Journal Of Neurology, Neurosurgery And Psychiatry
(7)
Journal Of Neuroimaging
(5)
The Lancet
(4)
Acta Neurologica Scandinavica
(3)
Bmj Open
(3)
Pain Medicine
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer

Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis

New‐onset atrial fibrillation incidence and associated outcomes in the medical intensive care unit

Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers

Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir

Renal scintigraphy in insulin-dependent diabetes mellitus: Early glomerular and urologic dysfunction

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics

Geographical variations in sex ratio trends over time in multiple sclerosis

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Aktive Filter

Suchergebnisse filtern